EUVIMEDObjevte EUVIMED
Klinische StudieOpen access · CC BY-NC 4.0

Introducing self‐sampling for cervical cancer screening: A regional implementation study in Pirkanmaa, Finland

Saara Kyllönen iD, Satu Saloranta, Saara Kares, Anu Mustila, Karolina Louvanto iD

Acta Obstetricia et Gynecologica Scandinavica · 2026

DOI: 10.1111/aogs.70273 ↗

At a glance

Klinische Studie in Acta Obstetricia et Gynecologica Scandinavica, 2026. Written by Saara Kyllönen and 4 co-authors. Institution: Department of Obstetrics and Gynecology, Faculty of Medicine and Health Technology, Tampere University, Tampere, Finland. Major MEDLINE topics: Early Detection of Cancer, Papillomavirus Infections, Self Care, Specimen Handling. Cited 2 times so far (Crossref); 33 references. The full text is freely available (open access, CC BY-NC 4.0). Funded by: Sigrid Juséliuksen Säätiö, Syöpäsäätiö (Cancer Foundation Finland), State funding for University-level Health Research, Tampere University Hospital, Wellbeing Services County of Pirkanmaa.

AbstraktSubjectsBibliografické údajeCiteRelated studies

Abstract (original language)

Introduction

HPV primary testing is the preferred method for cervical cancer screening worldwide and enables vaginal self‐sampling at home. Self‐sampling performs comparably to clinician‐collected samples and can improve participation, especially among non‐attenders. In Finland, self‐sampling has so far been piloted in the Helsinki region. This study evaluated the feasibility and acceptability of self‐sampling in Pirkanmaa, providing a representative model of implementation outside the capital region. Material and Methods The self‐sampling in cervical cancer routine screening (FALCON) study (NCT06931184) targeted women living in Pirkanmaa who did not respond to the initial cervical cancer screening invitation. In a reminder letter, they were offered an opt‐in model self‐sampling option. Participants ordered a self‐sampling kit containing a FLOQSwab (Copan), instructions, and a prepaid return envelope. Samples were analyzed with the Roche Cobas 4800 HPV assay at Fimlab Laboratories. HPV‐positive women were referred for cytology testing and managed according to national guidelines. Participants completed two online questionnaires: one at kit order and another 60 days later.

Results

Of 16 289 reminder letters, 329 kits were ordered, and 304 (1.9%) samples were returned.

Participants

(mean age 48 [range 29.9–65.8]) were mostly well‐educated with previous screening history. Time‐saving, reduced discomfort, and lower embarrassment were the main reasons for choosing home‐sampling. HPV was detected in 6.9% of the samples, with one case of histological HSIL identified. Most participants found self‐sampling easy and comfortable, and nearly all would recommend it to others.

Conclusion

Despite the small number of participants in this first year, the study offers early evidence of the strong acceptability and practicality of self‐sampling among women in Pirkanmaa, warranting further evaluation at a larger scale.

Subjects

MeSH terms (MEDLINE)

Early Detection of CancerPapillomavirus InfectionsSelf CareSpecimen HandlingUterine Cervical NeoplasmsVaginal SmearsAdultFemaleHumansMiddle AgedFeasibility StudiesFinlandPatient Acceptance of Health Care

Author keywords

HPV self‐samplingcervical cancer screeningscreening attendance

Authors and institutions

  • Department of Obstetrics and Gynecology, Faculty of Medicine and Health Technology, Tampere University, Tampere, Finland.
  • Department of Obstetrics and Gynecology, Tampere University Hospital, Tampere, Finland.
  • Fimlab Laboratories, Tampere, Finland.

ORCID profiles: Saara Kyllönen, Karolina Louvanto

Funding

  • Sigrid Juséliuksen Säätiö
  • Syöpäsäätiö (Cancer Foundation Finland)
  • State funding for University-level Health Research, Tampere University Hospital, Wellbeing Services County of Pirkanmaa
  • Roche Diagnostics

Cite

APA

Kyllönen, S., Saloranta, S., Kares, S., Mustila, A., & Louvanto, K. (2026). Introducing self‐sampling for cervical cancer screening: A regional implementation study in Pirkanmaa, Finland. Acta Obstetricia et Gynecologica Scandinavica. https://doi.org/10.1111/aogs.70273

Vancouver

Kyllönen S, Saloranta S, Kares S, Mustila A, Louvanto K. Introducing self‐sampling for cervical cancer screening: A regional implementation study in Pirkanmaa, Finland. Acta Obstetricia et Gynecologica Scandinavica. 2026. doi:10.1111/aogs.70273

BibTeX
@article{Kyllnen2026,
  author = {Kyllönen, Saara and Saloranta, Satu and Kares, Saara and Mustila, Anu and Louvanto, Karolina},
  title = {Introducing self‐sampling for cervical cancer screening: A regional implementation study in Pirkanmaa, Finland},
  journal = {Acta Obstetricia et Gynecologica Scandinavica},
  year = {2026},
  doi = {10.1111/aogs.70273}
}
Start for free →